Ayala Pharmaceuticals Inc Shares Close the Week 20.9% Higher - Weekly Wrap
The company saw its shares close the week 20.9% higher than last week, with trading volume higher than its 30 day average.
Jun 11, 2021 by Kwhen Finance Editors
Ayala Pharmaceuticals Inc (AYLA) shares closed this week 20.9% higher than it did at the end of last week. The stock is currently up 1.3% year-to-date, down 13.3% over the past 12 months, and down 25.8% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 rose 1.2%.
Trading Activity
- Shares traded as high as $12.18 and as low as $9.15 this week.
- Shares closed 6e+1% below its 52-week high and 3e+1% above its 52-week low.
- Trading volume this week was 68.3% lower than the 10-day average and 52.6% lower than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.9.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
- MACD, a trend-following momentum indicator, indicates an upward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
- The stock closed at 9.8% higher than its 5-day moving average, 14.0% higher than its 20-day moving average, and 9.1% lower than its 90-day moving average.
Market Comparative Performance
- The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price beats the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Ayala Pharmaceuticals Inc | 7.7 | 1.3 | -13.3 | -63.9 | 20.1 |
| Dow Jones Industrial Average | 0.0 | 13.6 | 30.1 | -1.3 | 41.6 |
| S&P 500 Index | 0.2 | 13.7 | 34.9 | -0.1 | 45.2 |
| Health Care | -0.8 | 9.8 | 30.9 | -0.3 | 33.3 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date beats the peer average by -105.0%
- The company's stock price performance over the past 12 months beats the peer average by -12.8%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Ayala Pharmaceuticals Inc | AYLA | 0 | 1.3 | -13.3 | -63.9 | 20.1 |
| Peer Avg | N/A | 0 | -26.6 | -15.3 | -29.2 | 6.5 |
| ORIC Pharmaceuticals Inc | ORIC | 0 | -42.3 | -38.8 | -50.7 | 8.1 |
| Otonomy Inc | OTIC | 0 | -64.0 | -22.3 | -66.0 | 17.9 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: